Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
about
Pharmacological importance of optically active tetrahydro-β-carbolines and synthetic approaches to create the C1 stereocenterSynthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.Peptide receptor targeting in cancer: the somatostatin paradigm.Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502)Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 Antagonist.Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes.Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor Agonists.Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q27026293-6C132630-0AB6-43A3-A581-C5111D2F162FQ30435057-9DEA9FBD-FAD3-4309-88F7-3E37B2876AF1Q33630394-5BC4ADB7-1548-4076-855A-7E4BB3258424Q36638046-34118B66-D9E5-410F-9ECA-A3971D627B7FQ36666706-26460887-1270-4323-AF03-48148DE7BEB6Q39528468-E41E81F3-17A1-4912-8AF4-A993D7EDFEC4Q39733685-43BD5F44-507A-43C5-A98D-90989860E5F3Q40648014-B8D5214D-B08E-482F-AC9A-EAE2ADBAEECEQ40753492-2AE1D7D6-2BEB-41AF-AE24-130E5646485FQ40809537-00BB6AC7-1F8E-40CB-8348-7594BA10E042Q42732674-6E80C09E-68B8-4EA0-B5C5-D105C99EBA88Q42959578-545A3F91-E1A6-43C2-9B25-0233FB787712Q57144951-BE100917-BA63-49EA-8F4F-F7D86CB897BA
P2860
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Identification of potent non-peptide somatostatin antagonists with sst
@nl
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
@en
type
label
Identification of potent non-peptide somatostatin antagonists with sst
@nl
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
@en
prefLabel
Identification of potent non-peptide somatostatin antagonists with sst
@nl
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
@en
P2093
P356
P1476
Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity.
@en
P2093
Contour-Galcéra MO
Thurieau C
P304
P356
10.1021/JM0108449
P407
P577
2001-08-01T00:00:00Z